A clinical study to see the effect of some Ayurvedic formulation in the treatment of near sightedness.

Single arm clinical trial to evaluate the efficacy of oral administration of Chitrakadi Kwatha in the management of Prathama-Dwitiya Patalagata Timira with reference to myopia.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053219

Enrollment

Registered

2023-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient Enrolled with symptoms of Prathama-Dwitiya Patalagata Timira i.e. Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of blurriness), Dooramnekshate (difficulty of distant vision) in Shalakya OPD. 2) Age-18 to 40 years. 3) Patient who have 4) Patient of either gender. 5) Patient having visual acuity of 6/12, 6/18, 6/24, 6/36, 6/60, or less than 6/60 in the eyes. 6) Patient who ready to give consent.

Exclusion criteria

Exclusion criteria: 1) Patient who have symptoms of Tritiya and Chaturtha Patalagata Timira will be excluded. 2) Congenital type of myopia, pathological type of myopia, acquired or secondary type of myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced, post keratitis. etc. will be excluded. 3) Myopia associated with other ocular diseases like cataract, glaucoma, etc. 4) Patient who have myopia associated with other refractive errors such as astigmatism, presbyopia. 5) Patient who have known case of hypertension, diabetes mellitus, Rheumatic arthritis or any other arthritic conditions, rheumatic heart disease, thyroid disorder, asthma, Kochâ??s, HIV will be excluded. 6) Patient who have active infectious diseases i.e. viral, fungal, bacterial conjunctivitis, trachoma, blepharitis. 7) Patient below 18 years and above 40 years will be excluded.

Design outcomes

Primary

Measure	Time frame
Symptoms like Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of bluriness), Dooramnekshate (difficulty of distant vision) will be decreased and relief from myopia.Timepoint: Follow of will be taken on 7th, 15th day and symptoms will be noted of before and after treatment.	—

Secondary

Measure	Time frame
Improvement in visual acuity of patient, decrease in severity and duration of symptomsTimepoint: 18months.	—

Countries

India

Contacts

Public ContactPROF DR MRS NILAKSHI PRADHAN

PUNE DEPARMENT OF SHALAKYATANTRA, MAMS SUMATIBHAI SHAH AYURVED COLLEGE, HADAPSAR.

drnspradhan@yahoo.com9423580963

Outcome results